Maravai LifeSciences (MRVI) News
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.98-0.21 (-2.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MRVI news summary
We found 6 recent headlines mentioning Maravai LifeSciences (MRVI): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, Business Wire, Seeking Alpha. For price context, MRVI is down 2.92% at $6.98. The most recent story, "Maravai LifeSciences Holdings Consensus Price Target Raised 11.76% to $9.69", was published by Nasdaq on Nov 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Maravai LifeSciences headlines
- Maravai LifeSciences Holdings Consensus Price Target Raised 11.76% to $9.69The average one-year price target for Maravai LifeSciences Holdings (NASDAQGS:MRVI) (DB:MAR) has been revised to $9.69 / share. This is an increase of 11.76% from the prior estimate of $8.67 dated…NasdaqMRVI, HEI.A
- Maravai LifeSciences Holdings, Inc. Reports Third Quarter 2026 Financial ResultsMaravai LifeSciences Holdings, Inc. reported its financial results for the third quarter ended September 30, 2026, with quarterly revenue of $45.9 million, representing a 10.1% increase compared to…Nasdaq
- Maravai LifeSciences Holdings Non-GAAP EPS of -$0.03 beats by $0.03, revenue of $45.9M beats by $2.34MSeeking Alpha
- Maravai LifeSciences Reports Third Quarter 2026 Financial ResultsSAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported…Business Wire
- Maravai LifeSciences Holdings Consensus Price Target Increased 11.84% to $8.67The average one-year price target for Maravai LifeSciences Holdings (NASDAQGS:MRVI) (DB:MAR) has been revised to $8.67 / share. This is an increase of 11.84% from the prior estimate of $7.75 dated…Nasdaq
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its…Business Wire